FENU, SANDRO
 Distribuzione geografica
Continente #
EU - Europa 125.313
NA - Nord America 8.932
AS - Asia 3.281
SA - Sud America 562
Continente sconosciuto - Info sul continente non disponibili 236
AF - Africa 54
OC - Oceania 5
Totale 138.383
Nazione #
IT - Italia 122.992
US - Stati Uniti d'America 8.788
SG - Singapore 1.322
CN - Cina 1.172
UA - Ucraina 705
BR - Brasile 459
SE - Svezia 408
DE - Germania 382
VN - Vietnam 272
FI - Finlandia 254
GB - Regno Unito 221
FR - Francia 177
HK - Hong Kong 124
KR - Corea 90
CA - Canada 83
IN - India 73
RU - Federazione Russa 51
BD - Bangladesh 35
AR - Argentina 33
EC - Ecuador 24
IQ - Iraq 23
JP - Giappone 23
TR - Turchia 23
MX - Messico 21
ES - Italia 20
BE - Belgio 17
PK - Pakistan 17
PL - Polonia 16
CO - Colombia 15
JM - Giamaica 15
ZA - Sudafrica 14
NL - Olanda 12
ID - Indonesia 11
IR - Iran 10
UZ - Uzbekistan 10
IE - Irlanda 9
MA - Marocco 9
PH - Filippine 9
EU - Europa 8
VE - Venezuela 8
SA - Arabia Saudita 7
AZ - Azerbaigian 6
DZ - Algeria 6
EG - Egitto 6
IL - Israele 6
KE - Kenya 6
UY - Uruguay 6
AL - Albania 5
CL - Cile 5
CR - Costa Rica 5
CZ - Repubblica Ceca 5
JO - Giordania 5
RO - Romania 5
TN - Tunisia 5
AU - Australia 4
BO - Bolivia 4
OM - Oman 4
PY - Paraguay 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
BB - Barbados 3
BG - Bulgaria 3
BN - Brunei Darussalam 3
CH - Svizzera 3
GT - Guatemala 3
LT - Lituania 3
MD - Moldavia 3
MY - Malesia 3
NP - Nepal 3
PE - Perù 3
PS - Palestinian Territory 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TH - Thailandia 3
BY - Bielorussia 2
CY - Cipro 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
LK - Sri Lanka 2
MN - Mongolia 2
NO - Norvegia 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AO - Angola 1
BW - Botswana 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
Totale 138.144
Città #
Cagliari 120.673
Uta 1.951
Ashburn 869
Fairfield 765
Woodbridge 712
Singapore 663
San Jose 569
Chandler 561
Houston 439
Ann Arbor 406
Jacksonville 382
Boardman 375
Dallas 370
Wilmington 354
Seattle 309
Nyköping 272
Cambridge 248
Beijing 192
Dearborn 157
Helsinki 146
Los Angeles 138
Santa Clara 129
Council Bluffs 118
Nanjing 117
Hong Kong 108
Lauterbourg 101
Ho Chi Minh City 96
Hefei 94
Boston 91
Seoul 88
The Dalles 82
Shanghai 79
Buffalo 69
New York 67
Hanoi 63
Milan 52
São Paulo 46
Guangzhou 45
San Diego 41
Toronto 40
Shenyang 38
Nanchang 32
Hebei 30
Redwood City 30
Chicago 28
Changsha 27
Jiaxing 27
Tianjin 27
Norwalk 26
Verona 25
Frankfurt am Main 19
Orem 19
Mountain View 17
Brussels 16
Washington 16
London 15
Tokyo 15
Auburn Hills 14
Montreal 14
Munich 14
Redondo Beach 14
Augusta 13
Brasília 13
Chennai 13
Kunming 13
Orange 13
Atlanta 12
Brooklyn 12
Upgant-schott 12
Zhengzhou 12
Hangzhou 11
Ningbo 11
Phoenix 11
Columbus 10
Jinan 10
Kingston 10
Rio de Janeiro 10
Rome 10
San Francisco 10
Curitiba 9
Da Nang 9
Mumbai 9
San Mateo 9
Tashkent 9
Campinas 8
Charlotte 8
Guarulhos 8
Haiphong 8
Istanbul 8
Quito 8
Saint Petersburg 8
Ardabil 7
Belo Horizonte 7
Biên Hòa 7
Juiz de Fora 7
Mexico City 7
Naples 7
New Delhi 7
Newark 7
Salvador 7
Totale 132.910
Nome #
Acquisition and expression of conditioned taste aversion differentially affects extracellular signal regulated kinase and glutamate receptor phosphorylation in rat prefrontal cortex and nucleus accumbens 4.618
null 4.110
Role of nucleus accumbens μ opioid receptors in the effects of morphine on ERK1/2 phosphorylation 4.067
Caffeine and the brain: an overview 3.750
Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: comparison of the effects of different psychoactive drugs and relevance in drug-induced reward 3.668
Immunomodulatory drugs alleviate l-dopa-induced dyskinesia in a rat model of Parkinson's disease 3.477
Strain dependence of adolescent Cannabis influence on heroin reward and mesolimbic dopamine transmission in adult Lewis and Fischer 344 rats 3.391
Behavioural pharmacology of caffeine 3.220
Evaluation of rewarding properties of pramipexole in a rat model of Parkinson’s disease: role of genetic background 3.117
Neuroinflammation in L-DOPA-induced dyskinesia: beyond the immune function 2.954
Behavioral Pharmacology of Caffeine 2.823
Conditioned saccharin avoidance induced by infusion of amphetamine in the Nucleus Accumbens shell and morphine in the Ventral Tegmental Area: behavioral and biochemical study 2.732
L dopa chronic treatment increases reactive microglia and tnf- alpha production in the 6-ohda lesioned striatum 2.718
In vivo dopamine agonist properties of rotigotine: Role of D1 and D2 receptors 2.688
Conditioned saccharin avoidance induced by infusion of amphetamine in the Nucleus Accumbens shell and morphine in the Ventral Tegmental Area: a behavioral and biochemical study 2.569
Disease modifying treatment with PPAR-gamma agonist rosiglitazone in a progressive mouse model of Parkinson's disease 2.517
Adolescent Cannabis exposure differentially affects heroin reinforcement and accumbens dopamine transmission in Lewis and Fischer344 rats 2.482
Possibile ruolo dei recettori 5-HT6 nelle dipendenze 2.269
null 2.160
null 2.148
Conditioned Saccharine Avoidance induced by infusion of amphetamine in the Nucleus Accumbens shell and morphine in the Ventral Tegmental Area 2.147
Conditioned Saccharine Avoidance induced by intra-Accumbens shell amphetamine and intra-VTA morphine 2.142
Influence of strain and age on voluntarily ethanol intake and on GAD-67 expression in the central amygdala 2.108
Behavioral and neurochemical pharmacology of 5-HT6 receptors related to reward and reinforcement 2.102
Morphine-conditioned single-trial place preference: role of nucleus accumbens shell dopamine receptors in acquisition, but not expression 2.048
Possibile ruolo dei recettori 5-HT6 nelle dipendenze - Possible role of 5-HT6 receptors in addictions 2.036
null 1.797
Pharmacological therapy of Parkinson's disease: current options and new avenues 1.793
Effect of adenosine A1 and A2A antagonists on 3,4 methylenedioxymethamphetamine (MDMA)-induced neuroinflammation and dopamine neuron toxicity in mouse brain 1.759
Nicotine-conditioned single-trial place preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition 1.747
Caffeine potentiation of 3,4-methylenedioxymethamphetamine (MDMA) toxicity: role of age 1.645
Reinforcing, rewarding and dopamine-stimulant properties of the 5-HT6 receptor agonist ST1936: the first member of a new class of psychostimulant? 1.601
REINFORCING, REWARDING AND DOPAMINE-STIMULANT PROPERTIES OF THE 5-HT6 RECEPTOR AGONIST ST1936: THE FIST MEMBER OF A NEW CLASS OF PSYCHOSTIMULANTS? 1.580
null 1.580
Controversie: Priming dopaminergico nel Parkinson. Il "priming" come modello sperimentale delle discinesie indotte da terapie dopaminergiche sostitutive nella Malattia di Parkinson 1.539
Blockade of globus pallidus adenosine A2A receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D1 or D2 dopamine receptor agonists 1.309
Effects of QO-IIR, a new COMT inhibitor, in experimental animal models of parkinson’s disease: behavioural, neurochemical and immunoistochemical study 1.295
Caffeine potentiates 3,4 methylenedioxymethamphetamine (MDMA, ecstasy)-induced-glial activation: role of age and adenosine A1 and A2A receptors 1.107
Differential involvement of dopamine D1 receptors in morphine- and lithium- conditioned saccharin avoidance 1.098
Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease 1.034
Role of Adenosine A1 and A2A receptors on 3,4-methylendioxymeth-amphetamine (MDMA, Ecstasy)-induced neurotoxicity, astroglia and microglia reactivity in mouse striatum and substantia nigra 1.022
Differential effect of MK 801 and scopolamine on c-fos expression induced by L-dopa in the striatum of 6-hydroxydopamine lesioned rats 985
Selective modifications in GAD67 mRNA levels in striatonigral and striatopallidal pathways correlate to dopamine agonist priming in 6-hydroxydopamine-lesioned rats 947
A role for dopamine D1 receptors of the nucleus accumbens shell in conditioned taste aversion learning 921
Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous L-DOPA delivery in the 6-OHDA model of Parkinson's disease 856
Alterations in GAD67, dynorphin and enkephalin mRNA in striatal output neurons following priming in the 6-OHDA model of Parkinson’s disease 844
Blockade of muscarinic receptors potentiates D1 dependent turning behavior and c-fos expression in 6-hydroxydopamine-lesioned rats but does not influence D2 mediated responses 827
Modulation of dopamine d1-mediated turning behavior and striatal c-fos expression by the substantia nigra 805
null 801
Effect of MK 801 on priming of D-1-dependent contralateral turning and its relationship to c-fos expression in the rat caudate-putamen 783
Conditioned saccharin avoidance and sensitization to drugs of abuse 776
“Priming” to dopamine agonist-induced contralateral turning as model of non associative sensitization to the expression of the post-synaptic dopamine message 774
Accumbens shell dopamine and stimulus-reward learning 770
Effetto del blocco dei recettori oppioidi delta sul turning controlaterale indotto dagli agonisti dopaminergici in ratti lesionati con la 6-idrossidopamina 734
Dopamine and drug addiction: the nucleus accumbens shell connection 715
Influence of Age and Genetic Background on Ethanol Intake and Behavioral Response Following Ethanol Consumption and During Abstinence in a Model of Alcohol Abuse 715
Behavioural expression of D-1 receptor supersensitivity depends on previous stimulation of D-2 receptors 700
Blockade of pallidal adenosine A2A receptors potentiates contralateral rotational behavior induced by L-DOPA and dopaminergic agonists in hemiparkinsonian rats 677
Conditioned saccharin avoidance and sensitization to drugs of abuse 674
Changes in GAD67 and peptides mRNA levels in specific populations of striatal efferent neurons following priming with dopamine agonists in 6-OHDA lesioned rats 663
Adenosine A2 Receptors interact negatively with dopamine D1 and D2 receptors in unilaterally 6-hydroxydopamine-lesioned rats 656
Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity. 643
Positive and negative interactions in the behavioural expression of D1 and D2 receptor stimulation in a model of parkinsonism: role of priming 643
Alterazioni nei livelli striatali di RNAm della GAD67, dinorfina e enkefalina, in seguito a priming con agonisti dopaminergici nel modello di morbo di parkinson della 6-ohda 642
Different involvement of Dopamine D1 receptor in morphine and lithium conditioned saccharin avoidance 640
 and  opiate receptors mediate specific behavioral syndromes from the Substantia Nigra. 636
Blockade of n-methyl-d-aspartate receptors potentiates dopaminergic responses in the 6-ohda model of parkinson: differential role of D1 and D2 receptors 635
Differential effect of priming with dopamine agonists on mrna for GAD-67, dynorphin and enkephalin in 6-OHDA lesioned rats 625
Effect of delta opioid receptors blockade on turning behavior induced by dopamine agonists in unilaterally 6-hydroxydopamine lesioned rats 617
Substantia nigra as a site of origin of dopamine-dependent motor syndromes induced by stimulation of mu and delta opioid receptors. 603
null 594
‘Priming’ phenomena in the expression of D1 and D2 receptor supersensitivity 587
Different involvement of dopamine D1 receptor in morphine- and lithium-induced conditioned saccharin avoidance 586
null 580
Opposite effects of nmda receptor blockade on dopaminergic d1-mediated and d2-mediated behavior in the 6-hydroxydopamine model of turning - relationship with c-fos expression 564
Differential role of dopamine in drug- and lithium conditioned saccharin avoidance 561
CONDITIONED TASTE AVERSION ELICITED ERK ACTIVATION AND CHANGES OF DENDRITIC SPINES DENSITY: AN IMMUNOHISTOCHEMICAL, GOLGI-COX AND ELECTRON MICROSCOPY STUDY 551
Blockade of n-methyl-d-aspartate receptors potentiates dopaminergic responses in the 6-ohda model of parkinson: differential role of D1 and D2 receptors 547
Opposite effects of NMDA receptor blockade on dopaminergic D1 and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression 536
Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors 530
Modulation of turning behavior induced by dopamine D1 agonists in 6-hydroxydopamine lesioned rats by intranigral infusion of glutamate antagonists. 529
null 515
null 504
The influence of priming on the behavioral expression of dopamine receptor supersensitivity in basal ganglia 492
null 479
Priming of the behavioral expression of dopamine-receptor supersensitivity in the basal ganglia: pharmacological and biochemical studies 456
Nicotine-conditioned single–trial place preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition 453
Priming of the behavioral of dopamine-receptor supersensitivity in the basal ganglia: pharmacological and biochemical studies 442
Differential role of dopamine in drug- and lithium-conditioned saccharin avoidance 441
Blockade of NMDA receptors differentially affects D1 and D2 mediated turning behavior in the 6-hydroxydopamine model of Parkinson 436
Cross-sensitization between the motor activating effects of bromocriptine and caffeine: role of adenosine A2A receptors 431
null 425
Ruolo dell’acetilcolina striatale sul turning indotto dagli agonisti dopaminergici D1 in un modello sperimentale di morbo di parkinson: studio combinato microdialisi/comportamento. 420
Dissociation of dopamine D1-induced turning behaviour and D1-induced increases in striatal acetylcholine release in 6-OHDA lesioned rats 416
Motor stimulant effects of caffeine in 6-hydroxydopamine lesioned rats are dependent on previous stimulation of dopamine receptors: a different role of D1 and D2 receptors 408
Facilitation of conditioned taste aversion learning by systemic amphetamine: role of nucleus accumbens shell dopamine D1 receptors 393
Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats 387
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease 377
Drug addiction as a disorder of associative learning. Role of nucleus accumbens shell/extended amygdala dopamine 365
Role of striatal acetylcholine on dopamine D1 receptor agonist-induced turning behavior in 6-hydroxydopamine lesioned rats: a microdialysis-behavioral study 360
Totale 131.639
Categoria #
all - tutte 183.281
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 183.281


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223.861 0 0 0 417 493 326 251 265 507 566 547 489
2022/20237.785 624 961 1.037 665 565 767 427 687 556 582 632 282
2023/202410.460 502 1.523 597 805 999 1.433 1.135 834 369 660 791 812
2024/202511.108 1.242 1.904 2.184 1.535 976 1.042 1.115 122 262 265 202 259
2025/20265.569 304 235 707 486 341 351 1.405 321 363 585 358 113
2026/20271.100 108 201 629 162 0 0 0 0 0 0 0 0
Totale 138.383